Patent Application
Provisional
App. No. 62/453,929
· Confirmation No. 4599
CANCER TREATMENT MODALITIES
Inventor:
Scott Ribich
Applicant:
Epizyme, Inc.
Provisional Application Expired
|
⬇ PDF
|
Code | Description | Pages | ||
|---|---|---|---|---|---|
| 2017-02-13 | APP.FILE.REC |
Filing Receipt | 3 | View | |
| 2017-02-02 | PA.. |
Power of Attorney | 2 | View | |
| 2017-02-02 | WFEE |
Fee Worksheet (SB06) | 2 | View | |
| 2017-02-02 | N417 |
Electronic Filing System Acknowledgment Receipt | 3 | View | |
| 2017-02-02 | TR.PROV |
Provisional Cover Sheet (SB16) | 3 | View | |
| 2017-02-02 | ADS |
Application Data Sheet | 8 | View | |
| 2017-02-02 | SPEC |
Specification | 110 | View | |
| 2017-02-02 | CLM |
Claims | 8 | View | |
| 2017-02-02 | ABST |
Abstract | 1 | View | |
| 2017-02-02 | DRW |
Drawings-only black and white line drawings | 3 | View |
Inventors
Scott Ribich
Lexington, MA
Attorneys & Agents of Record
Prosecution
- Customer No.
- 115357
- Docket No.
- EPIZ-074P01US 311622-2447
- Confirmation No.
- 4599
Child
PCT
Claims priority from a provisional application
→
PCT/US2018/016562
Filed 2018-02-02
· PCT - International Search Report Mailed to IB
Child
Claims priority from a provisional application
→
App. 16/482,748
Filed 2019-08-01
· Abandoned -- Failure to Respond to an Office Action
Child
Claims priority from a provisional application
→
App. 17/529,609
Filed 2021-11-18
· Abandoned -- Failure to Respond to an Office Action
from
BIOPHARMA CREDIT PLC
TERMINATION AND RELEASE OF SECURITY INTEREST IN PATENTS AT REEL/FRAME: 051057/0848
Recorded 2022-08-13
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this application's details
Quick Facts
- App. No.
- 62/453,929
- Filed
- 2017-02-02
External Links